TGFB1 and neoplasm: Unique among the four T‐cell mixtures tested, samples containing TGF‐β CAR‐T cells showed no significant change in tumor‐killing capability despite the presence of TGF‐β, resulting in significantly lower tumor‐cell survival compared to samples expressing the scFv‐less CAR or DNR (Figure 1c–f).